Volume 31, Issue 144 (January & February 2023)                   J Adv Med Biomed Res 2023, 31(144): 103-106 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Arfaatabar M, Azimi G, Masoorian E, Bagheri-Josheghani S, Ghobahi M, Pourmand M R. A Case Report of Severe Legionnaires’ Disease in Tehran, Iran. J Adv Med Biomed Res 2023; 31 (144) :103-106
URL: http://journal.zums.ac.ir/article-1-6496-en.html
1- Dept. of Medical Laboratory Sciences, Kashan Branch, Islamic Azad University, Kashan, Iran
2- Dept. of Internal Medicine, Shahed University of Medical Sciences, Tehran, Iran
3- Dept. of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
4- Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran
5- Infectious and Tropical Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbass, Iran
6- Dept. of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran , mpourmand@tums.ac.ir
Full-Text [PDF 386 kb]   (10550 Downloads)     |   Abstract (HTML)  (11349 Views)

✅ Currently, the culture method is considered as the “gold standard” for detection of L. pneumophila and  LD diagnosis. In this case report of severe LD in Iran, we studied a 60-year-old male patient with underlying chronic obstructive pulmonary disease (COPD).


Full-Text:   (965 Views)
Introduction
 

Legionella spp. is considered to play a key role in hospital-acquired (HA) and community-acquired pneumonia (CAP), especially in high-risk patients such as people over 50 years with immune system disorders or chronic lung diseases (1). Among Legionella species, L. pneumophila accounts for 3-15% of all CAP cases and is considered as the primary leading cause of Legionnaires’ disease (LD), which is an acute and atypical type of pneumonia (2). It has been reported that one in ten patients with LD dies due to the disease complications (3). Additionally, the mortality rate of patients developed LD during their stay in medical centers seems to be 25% (4). This discrepancy could be due to the similarity of the signs and symptoms of this disease and other respiratory ones, uncommon testing methods for this pathogen, and empiric antibiotic therapy for Legionella infections (2). Moreover, its mortality rate has been reported to be more than 60% in inappropriately-treated patients, which could be reduced to 10–20% by proper treatment (5).
 

 

Case Report

 In December 2017, a 60-year-old male patient with a history of COPD (chronic obstructive pulmonary disease) referred to the emergency section of a 310-bed hospital (Tehran, Iran) complaining about high fever, dyspnea, productive cough and fatigue, which lasted for three days. His vital signs at admission were as follows: body temperature: 38.4 °C, pulse rate: 120 beats/minute, respiration rate: 26 breaths/minute, and blood pressure: 120/73 mmHg. Wheezing and scattered bilateral crackles, especially at the base of the right lung, were identified through physical examination. The pressure of oxygen and carbon dioxide in his blood was assessed using arterial-blood gas test, the results of which revealed hypoxia and excessive alkalinity of the respiratory system (alkalosis) due to hyperventilation (PO2: 46 mmHg, PCO2: 27 mmHg, pH: 7.49, and HCO3: 21.3 mmol/L). Initial chest radiograph showed an abnormal edematous appearance of his chest, which was compatible with adult respiratory distress syndrome (ARDS) (Figure. 1).
 

 Figure 1. Chest X-ray at admission showing the features of adult respiratory distress syndrome (ARDS).
Figure 1. Chest X-ray at admission showing the features of adult respiratory distress syndrome (ARDS).

 
The patient was transferred to the intensive care unit (ICU) and was provided with primary care to avoid acute respiratory failure by endotracheal intubation. The results of his blood test were as follows: 134 mmol/L for sodium, 4.7 mmol/L for potassium, 106 mmol/L for chloride, 8.1 mmol/L (20 mg/dL) for BUN (blood urea nitrogen), and 118 μmol/L (1.3 mg/dL) for creatinine. The results of laboratory tests were remarkable for white blood cell count (WBC) (12.5/cumm), polymorphonuclear leukocytes (PMN) (73.9%), procalcitonin (PCT) (0.6 µgL-1, with a normal range of >0.05 µgL-1), and C-reactive protein (CRP) (118 mgL-1, with a normal range of >5 mgL-1). However, Influenza A (H1N1) RT-PCR, bronchoalveolar lavage (BAL) cytology, and Bacille de Koch (BK) smear of respiratory secretions were negative. Respiratory secretions were also tested for presence of Mycoplasma pnemoniae by culturing on PPLO (pleuropneumonia-like organism) broth and agar at Pathobiology Department of Tehran University of Medical Sciences and there was no growth of this pathogen. Molecular testing using 16S rRNA and p1 genes (6) was also negative for M. pneumoniae. Patient underwent emperic therapy using intravenous injection of piperacillin/tazobactam, vancomycin, imipenem, metronidazole, and Oseltamivir for five days, significantly deteriorated the clinical symptoms.
By cultivation of the specimens on BCYE agar (buffered charcoal yeast extract), L. pneumophila colonies appeared after four days of incubation (Fig. 2) and were confirmed by carbol-fuchsin Gram-staining (Fig. 3).
 

 Figure 2. L. pneumophila colonies on BCYE agar.
Figure 2. L. pneumophila colonies on BCYE agar.
 
 Figure 3. Gram-negative L. pneumophilia bacilli
Figure 3. Gram-negative L. pneumophilia bacilli

 
Rapid detection of L. pneumophila was performed via polymerase chain reaction (PCR) through partial sequencing of the mip gene (7). Identification of L. pneumophila in respiratory secretions caused antibiotic therapy to be changed and continued with levofloxacin. The patient was extubated four days after the start of intravenous injection of levofloxacin. After 30 days of intensive care, the follow-up appointment was satisfactory according to another chest radiograph, and he was discharged from the hospital with a prescription of oral clarithromycin for 10 days and other supplementary medications.


 

Discussion

Legionnaires' disease is a severe form of pneumonia. Several LD outbreaks have been reported so far. The first global outbreak of HAP due to LD was reported in Philadelphia in 1976. Relatively late detection of CA diseases seems to lead to delays in therapeutic interventions and proper antibiotic treatment. Improper antibiotic therapy could cause complications and increase mortality rate (as high as 80%) in patients with legionellosis, especially in immunocompromised ones (8). Currently, the culture method is considered as the “gold standard” for detecting Legionella and diagnosing Legionnaires' disease. Suitable and acceptable samples for culture are those collected from the lower airways, including sputum, bronchoalveolar lavage (BAL) fluid, pleural fluid, and bronchial aspirates (Fig. 2). Pulmonary tissue specimens and biopsy samples are also suitable for culturing. Samples less commonly used for culture are those collected from outside the lungs, such as blood, joint fluids, and soft tissues (9) since Legionella infection is rarely reported in these areas. These areas should be evaluated by culture method only when other etiologies are rejected. Generally, of all the potentially suitable specimens, the most frequently used samples for culture are those collected from sputum; however, most LD patients produce no or little sputum that is not sufficient for culture analysis.
The sensitivity of culture method for detection of Legionella strains in clinical samples varies from <10% to 80%, and isolates recovery depends on several factors, including the type of specimen and the specialized skills and experience of lab staff (10).
Studies have shown that in Iran, L. pneumophila was more prevalent during 2009–2016 (9.2%) compared to 2000–2008 (0.7%) (8).
This study was conducted on a case of atypical pneumonia. Recent studies have predicted that COPD would be the seventh most prevalent disease as well as the fourth most common cause of death in humans by 2030 (11). A previous study showed that in most patients with L. pneumophila CAP, chest radiographies (X-rays) were abnormal (12). However, distinct radiographic patterns, especially with patchy, pneumonic, infiltrate, or lobar consolidation and cavitation, could not confirm or reject LD in patients (13). Conversely, there is evidence showing that Legionella infections further exacerbate and worsen the disease in COPD patients compared to other respiratory pathogens (14). This could make it difficult for physicians to identify the infectious agent and provide appropriate treatment. Considering the fact that inappropriate treatment of LD could lead to 60–70% mortality (5), prompt diagnosis of LD as well as the initiation of effective therapy could reduce patient mortality. Information about LD in Iran is insufficient.
This study identified and reported a severe case of LD in a COPD patient in Iran and described its successful treatment with antibiotic therapy. The findings of this study suggest that physicians should pay more attention to atypical pathogens, such as Legionella spp., in patients with COPD, presenting an unusual form of pneumonia.


 

Conclusion

None.

 

Acknowledgements

This study was supported by Tehran University of Medical Sciences (Grant no.: 34054).

 

Conflicts of Interest

The authors have no conflict of interest to disclose.

 
 

Ethics approval and consent to participate

This study was reviewed and approved by Tehran University of Medical Sciences ethics committee (Grant no.: 34054).

 

Type of Study: Case Report Article | Subject: Clinical Medicine
Received: 2021/04/11 | Accepted: 2022/07/24 | Published: 2022/12/12

References
1. Control CfD, Prevention. Legionella (Legionnaires' disease and Pontiac fever). A-Z Index Available online: http://www cdc gov/legionella/about/diagnosis html (accessed on 6 December 2016). 2018.
2. Chamberlain AT, Lehnert JD, Berkelman RL. The 2015 New York city legionnaires' disease outbreak: A case study on a history-making outbreak. J Public Health Manag Pract. 2017;23(4):410. [DOI:10.1097/PHH.0000000000000558] [PMID] [PMCID]
3. Dooling KL, Toews KA, Hicks LA, et al. Active bacterial core surveillance for legionellosis-United States, 2011-2013. Morbid Mortal Week Rep. 2015;64(42):1190-3. [DOI:10.15585/mmwr.mm6442a2] [PMID]
4. Soda EA, Barskey AE, Shah PP, et al. Vital signs: health care-associated Legionnaires' disease surveillance data from 20 states and a large metropolitan area-United States, 2015. Am J Transplant . 2017;17(8):2215-2220 [DOI:10.1111/ajt.14407] [PMID]
5. Kassha K, Abuanza I, Hadi SA, Hilton R. Severe Legionnaires disease complicated by multi-organ dysfunction in a previously healthy patient: a case report. Cases J. 2009;2(1):1-3. [DOI:10.1186/1757-1626-2-9151] [PMID] [PMCID]
6. Arfaatabar M, Aminharati F, Azimi G, et al. High frequency of mycoplasma pneumoniae among patients with atypical pneumonia in Tehran, Iran. Germs. 2018;8(3):126. [DOI:10.18683/germs.2018.1139] [PMID] [PMCID]
7. McDonough EA, Barrozo CP, Russell KL, Metzgar D. A multiplex PCR for detection of mycoplasma pneumoniae, chlamydophila pneumoniae, legionella pneumophila, and bordetella pertussis in clinical specimens. Molec Cell Prob. 2005;19(5):314-22. [DOI:10.1016/j.mcp.2005.05.002] [PMID]
8. Khaledi A, Esmaeili SA, Vazini H, Karami P, Bahrami A, Sahebkar A. Evaluation of the prevalence of Legionella pneumophila in Iranian clinical samples: A systematic review and meta-analysis. Microb Pathogen. 2019;129:93-8. [DOI:10.1016/j.micpath.2019.02.008] [PMID]
9. Mercante JW, Winchell JM. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microb Rev. 2015;28(1):95-133. [DOI:10.1128/CMR.00029-14] [PMID] [PMCID]
10. Reller LB, Weinstein MP, Murdoch DR. Diagnosis of Legionella infection. Clin Infect Diseases. 2003;36(1):64-9. [DOI:10.1086/345529] [PMID]
11. Gómez-Junyent J, Garcia-Vidal C, Viasus D, et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. PloS one. 2014;9(8):e105854. [DOI:10.1371/journal.pone.0105854] [PMID] [PMCID]
12. Kümpers P, Tiede A, Kirschner P, Girke J, Ganser A, Peest D. Legionnaires' disease in immunocompromised patients: a case report of Legionella longbeachae pneumonia and review of the literature. J Med Microb. 2008;57(3):384-7. [DOI:10.1099/jmm.0.47556-0] [PMID]
13. McClelland MR, Vaszar LT, Kagawa FT. Pneumonia and osteomyelitis due to in a woman with systemic lupus erythematosus. Clin Infect Dis.38(10). [DOI:10.1086/386322] [PMID]
14. Ewig S. Legionella spp. in acute exacerbations of chronic obstructive pulmonary disease: what is the evidence? : Eur Respir J . 2002;(19)3: 387-9. [DOI:10.1183/09031936.02.00281402] [PMID]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb